According to Fuji Pharma latest financial reports the total liabilities of 4554 is $309.54M, an increase of 11.13% to 2022. At the end of 2022 company had $278.54M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Fuji Pharma is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $309.54M | 11.13% |
2022 | $278.54M | 25.91% |
2021 | $221.23M | 43.44% |
2020 | $154.23M | 2.94% |
2019 | $149.83M | 42.55% |
2018 | $105.11M | - |